Quest Diagnostics Htas India Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 54.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 27.97 Cr
as on 30-07-2024
- Company Age 7 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 8.64%
(FY 2023)
- Profit -0.05%
(FY 2023)
- Ebitda 6.10%
(FY 2023)
- Net Worth 21.93%
(FY 2023)
- Total Assets 18.98%
(FY 2023)
About Quest Diagnostics Htas India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 54.00 Cr and a paid-up capital of Rs 27.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Quest Diagnostics Htas India Private Limited India is Nagajyothi Gumpena as COMPANY SECRETARY. Brian Lapenna, Arvind Anthati, Goutham Valluru, and One other member serve as directors at the Company.
- CIN/LLPIN
U93090TG2017PTC132323
- Company No.
132323
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 2017
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Quest Diagnostics Htas India?
Executive Team (1)
NG
Nagajyothi Gumpena Company SecretaryAppointment Date: 19-Jul-2018
Status: Current
Board Members(4)
Financial Performance and Corporate Structure Insights of Quest Diagnostics Htas India.
Quest Diagnostics Htas India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.64% increase. The company also saw a slight decrease in profitability, with a 0.05% decrease in profit. The company's net worth Soared by an impressive increase of 21.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quest Diagnostics Htas India?
In 2023, Quest Diagnostics Htas India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quest Diagnostics India Private Limited
Active
18 years 18 days Brian Lapenna and Goutham Valluru are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quest Diagnostics Htas India?
Quest Diagnostics Htas India has a workforce of 221 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Sep 27, 2018, Quest Diagnostics Htas India has raised a total of ₹ 27.92 Cr, with the most recent deal valued at ₹ 16.87 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
